Within 14 working days of a person’s death as a result of the administration of medication under section 16, the attending medical practitioner, or the attending nurse practitioner who provided or administered the medication on the instruction of the attending medical practitioner, must send the rRegistrar a report in the prescribed approved form containing the information described in subsection (2).